Spots Global Cancer Trial Database for Demonstrate Efficacy and Safety of Metastatic Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Demonstrate Efficacy and Safety of Metastatic Breast Cancer
Official Title: Double-blind, Randomised, Parallel Group, Phase III Study
Study ID: NCT01084876
Conditions
Study Description
Brief Summary: The purpose of the study is to to demonstrate equivalence
Detailed Description: Patients will receive study drug every 3 weeks.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Investigational Site, Baia-mare, , Romania
Contact Details
Name: Investigational Site
Affiliation: Samsung Medical Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
